In the following video, Motley Fool health care bureau chief Brenton Flynn discusses two key takeaways he found after sifting through Intuitive Surgical's (NASDAQ: ISRG ) 2012 10-K report. He tells us how big the new market for single-site procedure kits could be, and how untapped that nascent market is at this point. He also notes a shift in the language that the company is using this year compared to last year. Last year, the report focused on developing patient value in its products, but this year Intuitive is also talking about value for the surgeons and hospitals. Brenton speculates that this might mean the company is finally addressing its bear detractors, who say that its surgical systems just aren't cost-efficient for hospitals yet.
Are stories of this demise greatly exaggerated?
Recently, some investors have questioned Intuitive Surgical's future. However, Intuitive Surgical expert Karl Thiel believes a visible path to long-term growth persists. Will Intuitive capitalize, or be crushed by unforeseen pitfalls? His report highlights all of the key opportunities and risks facing the company -- and includes a full year of ongoing updates as key new hits -- so be sure to claim your copy by clicking here now.